Online:
Visits:
Stories:
Profile image
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

Development of new Biotechnological Diagnostic Techniques is expected to added fuel in the growth of Nucleic Acid Amplification Test Market Till 2025

Tuesday, March 14, 2017 4:51
% of readers think this story is Fact. Add your two cents.

(Before It's News)

The global nucleic acid amplification test (NAAT) market is expected to reach USD 4.4 Billion by 2025, according to a new report by Grand View Research, Inc. Nucleic acid amplification testing is gaining preference over traditional diagnostic techniques because of its high efficiency and accuracy. In addition, the potential application of these tests in various life-threatening diseases, including several types of cancer, is attracting a large amount of investment for the purpose of R&D. Increasing number of ongoing studies are expected to ensure higher growth rate in the later part of the forecast period.

These tests are currently being used extensively for screening and diagnosis of a wide range of infectious diseases. Along with known infectious diseases, management of epidemics of new diseases has caused a sudden surge in the demand for advanced diagnostic tests. NAAT is currently the most advanced and efficient diagnostic method, which extensively uses technology that helps in reducing procedural time and consumption of reagents.

Access Full Research Report on Nucleic Acid Amplification Test Market
http://www.grandviewresearch.com/industry-analysis/nucleic-acid-amplification-testing-naat-market

Further Key Findings from the Study Suggest:

  • The market study suggests that infectious diseases segment captured the largest revenue share in 2015 owing to the high demand for effective screening methods for management of these diseases
  • Cancer is expected to exhibit the fastest growth during the forecast period due to the rising number of studies to develop tests for early detection of various cancer types
  • Expanding applications prenatal screening and for the detection of mitochondrial disorders is expected to boost the demand for NAAT
  • High usage of the PCR technique in NAT is driving the growth of the segment and is expected to capture significant revenue share in the near future
  • North America dominated the space in 2015 with U.S. capturing the largest share
  • Evolution of biotechnology sector in the Asia Pacific, along with the favorable government initiatives, Asia Pacific is expected to show the fastest growth rate during the forecast period
  • A few of the major players in the market are F. Hoffmann-La Roche Ltd; Bio-Rad Laboratories, Inc.; Becton, Dickinson and Company; Novartis AG; Beckman Coulter, Inc.; bioMérieux SA; Abbott Laboratories; Siemens Healthineers, and Illumina, Inc.

Read Our Blog: http://www.grandviewresearch.com/blog/nucleic-acid-amplification-test-market-size-share

Grand View Research has segmented the nucleic acid amplification test market on the basis of application, technique, and region:

Nucleic Acid Amplification Test Application Outlook (Revenue, USD Million, 2014 – 2025)

  • Infectious Diseases
    • Virus
    • Bacteria
    • Others
  • Cancer
  • Personalized Medicine
  • Genetic and Mitochondrial Disorders

Nucleic Acid Amplification Test Technique Outlook (Revenue, USD Million 2014 – 2025)

  • Target amplification systems
  • Probe amplification systems
  • Signal amplification

Nucleic Acid Amplification Test Regional Outlook (Revenue, USD Million, 2014 – 2025)

  • North America
    • US.
    • Canada
  • Europe
    • UK
    • Germany
  • Germany Asia Pacific
    • China
    • India
  • Latin America
    • Brazil
    • Mexico
  • MEA
    • South Africa 

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: [email protected]
For More Information: www.grandviewresearch.com

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories
 

Featured

 

Top Global

 

Top Alternative

 

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.